U.S. gives green light to Moderna’s COVID-19 vaccine
By
Alicia Lasek
Feb 01, 2022
“Spikevax” is the second COVID-19 mRNA vaccine to receive full FDA approval, following Pfizer-BioNTech’s Comirnaty in September.
Shot targeting omicron may be ready by March, Pfizer predicts
By
Alicia Lasek
Jan 11, 2022
The company says it is working with partner BioNTech to develop a shot that will combine its original vaccine with a drug that helps build immunity to the highly transmissible omicron variant.
Clinical briefs for Monday, Jan. 10
By
Alicia Lasek
Jan 10, 2022
Supreme Court grills attorneys over worker COVID-19 vaccination mandates … FDA shortens booster interval for Moderna vaccine to five months … Dementia prevalence estimated to increase to 152 million...
Moderna’s booster neutralizes omicron; protection will last through winter, drugmaker says
By
Alicia Lasek
Dec 21, 2021
At 50 micrograms, a booster of Moderna’s vaccine increases antibody levels by 37-fold against the SARS-CoV-2 omicron variant, the company reported Monday.
Pfizer, Moderna vaccines recommended over Johnson & Johnson’s coronavirus shot
By
Alicia Lasek
Dec 17, 2021
Americans should preferably be vaccinated with the Pfizer-BioNTech or Moderna COVID-19 vaccines due to a rare but serious risk of blood clots and the lesser protection found with the J&J vaccine, CDC says.
mRNA-1273 has high vaccine effectiveness after five months
Dec 03, 2021
Vaccine effectiveness 87.4 percent against COVID-19 infection, and 95.8 and 97.9 percent against COVID-19 hospitalization, hospital death
CDC advises COVID boosters for all adults, citing worrisome omicron variant
By
Alicia Lasek
Nov 30, 2021
The new recommendation comes amid rising concerns about the omicron coronavirus variant — yet another reason to get an additional vaccine dose, health officials say.
Protection declines dramatically over time for all three COVID-19 vaccines: study
By
Amy Novotney
Nov 08, 2021
As the delta variant became the dominant strain of coronavirus across the United States, all three COVID-19 vaccines available to Americans lost some of their protective power, with vaccine efficacy among...
FDA expands COVID booster shot access; says vaccines can be mixed or matched
By
Alicia Lasek
Oct 21, 2021
The agency has amended the emergency use authorizations for Moderna’s and Johnson & Johnson’s COVID-19 vaccines to allow for the use of a single booster dose in certain eligible groups.
Federal health officials to OK mix-and-match booster vaccinations: report
By
Alicia Lasek
Oct 20, 2021
Clinicians will be free to administer any of the three U.S.-approved COVID-19 vaccines to eligible recipients once Moderna and Johnson & Johnson booster shots are authorized, sources say.